FDA Must Improve Medical Device Oversight, GAO Says

Law360, New York (April 13, 2011, 7:29 PM EDT) -- The U.S. Government Accountability Office told a Senate committee Wednesday that the Food and Drug Administration must improve its oversight of medical devices needs, including premarket testing of the devices and oversight of recalls and devices already on the market.

In a Senate Aging Committee hearing, Marcia Crosse, director of the GAO's health care team, said the oversight of medical devices such as pacemakers and hip implants was placed on the GAO's "high-risk" list in 2009 and remains a concern in 2011.

Crosse was critical of...
To view the full article, register now.